Form 4: ANI Pharmaceuticals SVP, Generics, Ori Gutwerg, Sells Shares

Ori Gutwerg, SVP, Generics at ANI Pharmaceuticals, sold 881 shares of common stock at an average price of $60.07 on May 15, 2025.

Summary

• On May 15, 2025, Ori Gutwerg, the SVP of Generics at ANI Pharmaceuticals, sold 881 shares of the company's common stock.
• The sale was executed at a weighted average price of $60.07 per share, with individual sales prices ranging from $60.06 to $60.09.
• Following the transaction, Gutwerg directly owns 89,897 shares of ANI Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of an insider transaction. The sale itself doesn't necessarily indicate a positive or negative outlook.

Industry Context

This is a routine disclosure of an insider stock sale. It's common for executives to periodically sell shares for personal financial management.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, but it is a common practice and doesn't necessarily reflect the company's performance.

Key Dates

Keywords

ANI Pharmaceuticals, ANIP, Ori Gutwerg, SEC Form 4, Stock Sale, Insider Trading, Generics, SVP